PT  - JOURNAL ARTICLE
AU  - Yin, Liangying
AU  - Liu, Menghui
AU  - Shi, Yujia
AU  - Qiu, Jinghong
AU  - So, Hon-cheong
TI  - Direct causal variable discovery leveraging the invariance principle: application in biomedical studies
AID  - 10.1101/2024.08.29.24312763
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.08.29.24312763
4099  - http://medrxiv.org/content/early/2024/08/29/2024.08.29.24312763.short
4100  - http://medrxiv.org/content/early/2024/08/29/2024.08.29.24312763.full
AB  - Accurate identification of direct causal(parental) variables for a target is of primary interest in many applications, especially in biomedicine. It could promote our understanding of the underlying pathophysiological mechanism and facilitate the discovery of new biomarkers and therapeutic targets for studied clinical outcomes. However, many researchers are inclined to resort to association-based machine learning methods to identify outcome-associated variables. And many of the identified variables may prove to be irrelevant. On the other hand, there is a lack of an efficient method for reliable parental set identification, especially in high-dimensional settings (e.g., biomedicine).Here, we proposed a novel and efficient two-stage approach (I-GCM) to discover the direct causal variables (including genetic and clinical variables) for various outcomes. Variable selection was first performed by the PC-simple algorithm. Then it exploited the invariance of causal relations in different (experimental) settings, which was represented by generalized covariance measure calculated from gradient-boosted trees, for efficient and reliable causal variable discovery.We first verified the proposed method through extensive simulations. This approach constantly yielded high precision (a.k.a., positive predictive value) and specificity while maintaining satisfactory sensitivity in general, and consistently outperformed a standard Notably, the precision was larger than 90% in our simulated scenarios, even in high-dimensional settings. We then applied the proposed method to 4 clinical traits to uncover the corresponding direct causal variables. Encouragingly, many identified clinical variables, genes and pathways were supported by the literature. Our proposed method constantly achieved superior performance in identifying actual direct causal variables, making it particularly useful in selecting what (genetic/clinical) risk factors to follow up. Importantly, our work represents one of the first applications of the invariance principle for causal inference in biomedical or clinical studies, and suggests a new avenue for causal discovery in these settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported partially by a National Natural Science Foundation China grant (81971706), the Lo Kwee Seong Biomedical Research Fund from The Chinese University of Hong Kong and the KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research of Common Diseases, Kunming Institute of Zoology and The Chinese University of Hong Kong, China.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UK biobank data is available to any researchers who formally apply for the data. However, the data is not publicly available due to privacy concerns.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesUK biobank data is available to any researchers who formally apply for the data. However, the data is not publicly available due to privacy concerns.